|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Definitions and diagnosis显示文摘 | Gert Van Assche Axel Dignass Julian Panes Laurent Beaugerie John Karagiannis Mathieu Allez Thomas Ochsenkühn Tim Orchard Gerhard Rogler Edouard Louis Limas Kupcinskas Gerassimos Mantzaris Simon Travis Eduard Stange | 2009 | Journal of Crohn’s and Colitis2009，，1： | 10 |
| 2 | Role of endoscopy in predicting the disease course in inflammatory bowel disease显示文摘Endoscopy provides a direct evaluation of mucosal lesions in inflammatory bowel disease(IBD),permitting the description of elementary lesions,their surface extent and severity.The severity of mucosal lesions directly reflects disease activity and may help to identify an aggressive behavior of the disease.Several studies have recently pointed out the potential role of endoscopy in the prediction of IBD outcome.Indeed,severe endoscopic lesions in Crohn's disease(CD) patients,defined by deep and extensive ulcerations on at least one part of the colon,are associated with an increased risk of penetrating complication and surgery.Severe endoscopic lesions during severe attacks of ulcerative colitis(UC) are associated with an increased risk of colectomy in the short and long term.Severity of postoperative recurrence in CD may help to predict the risk of clinical relapse and need for further surgery.Achievement of mucosal healing,which can be obtained by administration of several types of drugs,is associated with a better outcome,less surgery and hospitalization.This review focuses on the assessment of endoscopic severity in CD and UC and on the impact of endoscopic severity on disease outcome.More specifically,we discuss how endoscopy can be used at different stages of IBD to predict the disease course and/or to adapt treatment strategies. | Matthieu Allez Marc Lémann | 2010 | World Journal of Gastroenterology2010，16，21： | 10 |
| 3 | Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn’s Disease显示文摘 | Pierre Desreumaux Arnaud Foussat Matthieu Allez Laurent Beaugerie Xavier Hébuterne Yoram Bouhnik Maria Nachury Valérie Brun Hervé Bastian Nathalie Belmonte Michel Ticchioni Agnès Duchange Patricia Morel–Mandrino Virginie Neveu Nathalie Clerget–Chossat Mig | 2012 | Gastroenterology2012，，5： | 4 |
| 4 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management显示文摘 | Axel Dignass James O. Lindsay Andreas Sturm Alastair Windsor Jean-Frederic Colombel Mathieu Allez Gert D’Haens André D’Hoore Gerassimos Mantzaris Gottfried Novacek Tom ?resland Walter Reinisch Miquel Sans Eduard Stange Severine Vermeire Simon Travis Gert | 2012 | Journal of Crohn’s and Colitis2012，，10： | 4 |
| 5 | Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease显示文摘The incidence of inflammatory bowel diseases(IBD)is rising worldwide.The therapeutic options for IBD are expanding,and the number of drugs with new targets will rapidly increase in coming years.A rapid step-up approach with close monitoring of intestinal inflammation is extensively used.The fear of side effects represents one the most limiting factor of their use.Despite a widespread use for years,drug induced liver injury(DILI)management remains a challenging situation with Azathioprine and Methotrexate.DILI seems less frequent with anti-tumor necrosis factor agents and new biologic therapies.The aim of this review is to report incidence,physiopathology and practical guidelines in case of DILI occurrence with the armamentarium of old and new drugs in the field of IBD. | My-Linh Tran-Minh Paula Sousa Marianne Maillet Matthieu Allez Jean-Marc Gornet | 2017 | World Journal of Hepatology2017，9，13： | 3 |
| 6 | Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial显示文摘 | David Laharie Arnaud Bourreille Julien Branche Matthieu Allez Yoram Bouhnik Jerome Filippi Frank Zerbib Guillaume Savoye Maria Nachury Jacques Moreau Jean-Charles Delchier Jacques Cosnes Elena Ricart Olivier Dewit Antonio Lopez-Sanroman Jean-Louis Dupas F | 2012 | The Lancet2012，，9857： | 2 |
| 7 | Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease显示文摘 | Benjamin Pariente Guillaume Pineton de Chambrun Roman Krzysiek Marine Desroches Gauthier Louis Chiara De Cassan Clotilde Baudry Jean‐Marc Gornet Pierre Desreumaux Dominique Emilie Jean‐Frédéric Colombel Matthieu Allez | 2011 | Inflamm Bowel Dis2011，，7： | 2 |
| 8 | Early Administration of Azathioprine vs Conventional Management of Crohn’s Disease: a Randomized Controlled Trial显示文摘 | Jacques Cosnes Anne Bourrier David Laharie Stéphane Nahon Yoram Bouhnik Franck Carbonnel Matthieu Allez Jean-Louis Dupas Jean-Marie Reimund Guillaume Savoye Pauline Jouet Jacques Moreau Jean-Yves Mary Jean-Frédéric Colombel | 2013 | Gastroenterology2013，，： | 2 |
| 9 | Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease显示文摘 | Harry Sokol Laurent Beaugerie Marc Maynadié David Laharie Jean‐Louis Dupas Bernard Flourié Eric Lerebours Laurent Peyrin‐Biroulet Matthieu Allez Tabassome Simon Fabrice Carrat Nicole Brousse | 2012 | Inflamm Bowel Dis2012，，11： | 1 |
| 10 | Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease显示文摘 | Brimnes J Allez M Dotan I | | 0，，09： | 1 |
| 11 | The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Definitions and diagnosis显示文摘 | Gert Van Assche Axel Dignass Julian Panes Laurent Beaugerie John Karagiannis Mathieu Allez Thomas Ochsenkühn Tim Orchard Gerhard Rogler Edouard Louis Limas Kupcinskas Gerassimos Mantzaris Simon Travis Eduard Stange | 2009 | Journal of Crohn’s and Colitis2009，，1： | 1 |
| 12 | Expansion of CD8+T cells with regulatory function after interaction with intestinal epithelial cells显示文摘 | Allez M Brimnes J Dotan I | 2002 | Gastroenterology2002，123，5： | 1 |
| 13 | Activation of a unique population of CD8(+)T cells by intestinal epithelial cells显示文摘 | Allez M Brimnes J Shao L | 2004 | Ann N Y Acad Sci2004，1029，1： | 1 |
| 14 | 561 Successive Treatment with Cyclosporine and Infliximab in Severe Ulcerative Colitis (UC)显示文摘 | Sarah Leblanc Matthieu Allez Philippe Seksik Bernard Flourie Harald Peeters Jean-Louis Dupas Guillaume Bouguen Laurent Peyrin Biroulet Arnaud Bourreille Olivier Dewit Yoram Bouhnik Pierre F. Michetti Stanislas Chaussade Philippe de Saussure Jean-Frederic | 2009 | Gastroenterology2009，，5： | 1 |
| 15 | Eigenvector dynamics: gen- eral theory and some applications 显示文摘 | ALLEZ R BOUCHAUD J P | 2012 | Physical Review E2012，86，04： | 1 |
| 16 | Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease显示文摘 | Brimnes J Allez M Dotan I | | 0，，09： | 1 |
| 17 | CD4+NKG2D+T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions显示文摘 | Allez M Tieng V Nakazawa A | 2007 | Gastroenterology2007，132，7： | 1 |
| 18 | Successive treat- ment with eyclosporine and infliximab in steroid - refracto- ry ulcerative colitis 显示文摘 | Leblanc S Allez M Seksik P | 2011 | Am J Gastroenterol2011，106，4： | 1 |
| 19 | CD4+NKG2D+ T cellsin Crohn,s disease mediate inflammatory and cytotoxicresponses through MICA interactions 显示文摘 | Allez M Tieng V Nakazawa A | 2007 | Gastroenterology2007，132，7： | 1 |
| 20 | Defects in CD8+Regulatory T Cells in the Lamina Propria of Patients with Inflammatory Bowel Disease显示文摘 | Brimnes J Allez M Dotan I | 2005 | J Immunol2005，174，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员